Scientist I - Neuro Discovery

About the Department

Dicerna, a Novo Nordisk company, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease. Our proprietary GalXC™ and GalXC-Plus™ RNAi technologies have the potential to address conditions that are difficult or impossible to treat with other modalities. Established as a Transformational Research Unit (TRU) following Novo Nordisk’s acquisition of Dicerna Pharmaceuticals, Inc. in December 2021, the Dicerna TRU is a unique new organization within Novo Nordisk that brings together the best of both worlds – the agility, collaborative pioneering spirit and calculated risk-taking profile of a biotech along with the scale, resources and capabilities of a global leader in drug development. With approximately 200 researchers, scientists, drug developers and operational staff, we are a team of inventive and entrepreneurial thinkers pushing the boundaries of science to create and drive new RNAi-based therapies for both rare and more prevalent diseases from the bench to the clinic. Together, we are driving change. Are you ready to make a difference?

The Position

Dicerna is a rapidly growing biopharmaceutical company focused on the discovery and development of innovative therapeutics for rare diseases, chronic liver diseases, cardiovascular diseases, infectious diseases, and  diseases of the brain and eye. The Company is using its proprietary GalXC™ and GalXC-Plus™ RNAi technology platforms to build a broad pipeline in these therapeutic areas. We offer a unique and exceptional culture that thrives on energy, sharing of ideas and overall excellence. We believe in career development and enhancing the work environment with industry-leading perks (daily catered lunches, fun corporate outings, community volunteering opportunities, bonus incentive program). We offer competitive salaries and excellent benefits.

We are seeking a highly skilled PhD scientist to join their Neuro Discovery group. This individual will be a key player in the identification and establishment of new targets utilizing Dicerna's RNAi therapeutics in the central and peripheral nervous systems in order to broaden Dicerna's CNS pipeline. This individual will also play a key role in bridging the gaps between platform development and target lead ID.

Relationships

This position reports to the Scientist II, Research – Neuro/Ocular.

Essential Functions

Physical Requirements

0-10% overnight travel required. Ability to lift 0 - 50 lbs.

Qualifications

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.

Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.